Skip to main content
Affiliate Disclosure: Some links earn a small commission at no extra cost to you. I only recommend platforms I've researched. Learn more
  1. Articles/

Best Telehealth for GLP-1 Prescriptions (2026)

Compounded semaglutide and tirzepatide from licensed providers — no insurance needed.

💊
From $99/mo
Compounded GLP-1s vs $1,000+ list price for brand-name
4 Vetted Platforms
Licensed providers + state-licensed US 503A pharmacies
🚫
No Insurance
Cash-pay: no prior authorizations, no denials to fight

Skip the insurance fight. These telehealth platforms connect you with licensed providers who prescribe compounded GLP-1 medications — delivered to your door, no insurance needed. Whether you’re using GLP-1s for weight management, inflammation, or a specific health condition, the process is the same.

Every platform below passes the same vetting: a licensed clinician reviews your health history, and medication comes from a state-licensed US 503A compounding pharmacy. That’s the line between medicine and gray-market retail.

Read: 7 Platforms Ranked by Price →


Where to Get GLP-1s Online #

PlatformStarting PriceMedicationBest For
Oak Loves You$133/mo (sema), $199/mo (tirz)Compounded semaglutide & tirzepatideFree coaching, same-day approval, price matching, all 50 states
Gala$129/mo sema, $179/mo tirzCompounded semaglutide & tirzepatideCheapest tirzepatide, free coaching & dietitian, $0 membership
ShedRx$159/moCompounded semaglutide & tirzepatide (injections, drops, lozenges)Health coaching included, 120-day money-back guarantee
YourEra HealthFrom $99/mo (6-month plan)Compounded semaglutide & tirzepatideOwn pharmacy, physician-led, LegitScript certified, Klarna
All platforms include: Licensed provider consultation, prescription, medication shipped to your door. No insurance required.

We may earn a commission if you sign up through these links, at no extra cost to you. Full disclosure.


Compounded vs Brand-Name: Price Comparison #

Here’s the math that drives most people to telehealth in the first place. Brand-name GLP-1 medications cost $1,000-1,349 per month at list price. Compounded versions of the same active ingredients cost $129-329 per month.

MedicationTypical Monthly CostNotes
Wegovy (brand semaglutide)~$1,349 list priceFDA-approved for weight management, MASH
Ozempic (brand semaglutide)~$1,000 list priceFDA-approved for type 2 diabetes
Zepbound (brand tirzepatide)~$1,086 list priceFDA-approved for weight management, sleep apnea
NovoCare / LillyDirect self-pay~$349-499/moManufacturer direct-pay programs for cash patients
Compounded semaglutide$129-199/moVia telehealth + 503A compounding pharmacy
Compounded tirzepatide$179-329/moVia telehealth + 503A compounding pharmacy
The insurance reality: Insurance rarely covers GLP-1 medications for anything other than type 2 diabetes or (sometimes) obesity — and even those approvals often require prior authorization and appeals. For off-label uses like the conditions covered on this site (lupus, arthritis, mental health), insurance coverage is essentially zero. That's why cash-pay pricing matters so much.

If your insurance covers brand-name for an FDA-approved indication, take that path. If it doesn’t — and for most people it doesn’t — the realistic choices are manufacturer self-pay programs at $349-499/month or compounded medication at $129-329/month.


Is Telehealth GLP-1 Legit? How to Vet a Platform #

Short answer: the good ones are, and the bad ones are easy to spot once you know what to look for. Telemedicine prescribing is legal in all 50 states, and the platforms I recommend use licensed providers and state-licensed US pharmacies. But the GLP-1 gold rush attracted sketchy operators too. Here’s how to tell the difference.

Green flags — signs a platform is legitimate

  • Licensed providers in your state — a real clinician reviews your case and can be contacted
  • US 503A state-licensed compounding pharmacy — the platform names its pharmacy partner and it's licensed by a state board of pharmacy
  • Requires a health questionnaire (and sometimes labs) — a platform that screens you is a platform practicing medicine
  • Transparent pricing — the monthly cost, what's included, and cancellation terms are stated up front
  • Real medical support — you can message a provider about side effects and dose adjustments after purchase

Red flags — walk away if you see these

  • No prescription required — selling semaglutide without a prescription is illegal, full stop
  • Ships from overseas — no US pharmacy oversight, no quality guarantee, possible customs seizure
  • "Research use only" labeling — research-grade peptides are not made for human use and are not sterile-tested to pharmacy standards
  • No provider consultation — if nobody reviews your health history, it's not medicine, it's retail
  • Prices too good to be true — legitimate compounded semaglutide costs $129+/month; a "$50/month" offer is cutting a corner you can't see
  • No pharmacy name disclosed — legitimate platforms tell you exactly who fills your prescription

Every platform in the comparison table above passes the green-flag checklist. That’s why they’re the only four I list.


This is the part most sites get wrong or leave conveniently vague, so let me be precise about the timeline.

During the shortage (2022-2024), federal law allowed compounding pharmacies — including large 503B outsourcing facilities — to produce copies of semaglutide and tirzepatide because the brand-name drugs were officially in shortage. That’s when compounded GLP-1s exploded in popularity.

The shortage ended. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025. A grace period followed, and by mid-2025 the window for mass-producing compounded copies had closed. Since then, the FDA has actively enforced against large-batch compounders.

What’s still legal in 2026: Compounding through state-licensed 503A pharmacies remains legal when a prescriber documents an individualized clinical need for a specific patient — for example, a dose that isn’t commercially available, or an allergy to an inactive ingredient in the brand-name product. This is traditional, patient-specific compounding, and it’s how legitimate telehealth platforms operate today.

What happened in April 2026: The FDA proposed removing semaglutide and tirzepatide from the 503B bulk substances list entirely — which would formally end any remaining pathway for outsourcing facilities to mass-produce these drugs — and issued roughly 30 warning letters to compounders. The public comment period ran through June 29, 2026, and a final decision is pending.

What this means for you: The compounded GLP-1 space in 2026 is significantly more regulated than it was in 2024 — and honestly, that's a quality filter. The fly-by-night operators selling mass-produced vials are being squeezed out. The platforms still standing work with state-licensed 503A pharmacies and write individualized prescriptions. Before you order from anyone, verify two things: the prescription comes from a licensed provider, and the medication comes from a state-licensed US pharmacy.

I’ll keep this section updated as the FDA’s 503B decision is finalized.


Do I Qualify? #

Telehealth platforms follow the same prescribing criteria used for FDA-approved weight management medications. The typical requirements:

You’ll typically qualify if you have:

  • BMI 30 or higher, or
  • BMI 27 or higher plus at least one weight-related condition, such as:
    • Sleep apnea
    • High blood pressure
    • Prediabetes
    • High cholesterol
    • PCOS
    • Arthritis / joint pain
    • Fatty liver disease

Notice something? The conditions covered on this site — sleep apnea, arthritis, fatty liver — are exactly the kind of comorbidities that qualify you at BMI 27+. Your health condition isn’t a barrier to access; it’s often the thing that gets you approved.

You will NOT qualify if you have:

  • Pregnancy or breastfeeding — GLP-1s should be stopped at least 2 months before trying to conceive
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN2 — absolute contraindication for all GLP-1 medications
  • History of pancreatitis — case-by-case; some providers will decline, others will discuss risks
  • Type 1 diabetes — case-by-case; requires closer medical supervision than most telehealth platforms provide

Be honest on the questionnaire. The screening exists to protect you, and providers can only make a safe call with accurate information.


How Telehealth GLP-1 Prescriptions Work #

1
Fill out a health questionnaire

Takes about 10 minutes. Include your health conditions, current medications, and goals.

2
Licensed provider reviews your case

A licensed physician evaluates your health history and determines if GLP-1 medication is appropriate for you.

3
Medication ships to your door

Pre-mixed, ready to inject. Shipped cold with everything you need. Typically arrives in 3-10 business days.

What to Expect: The First 90 Days #

Here’s the realistic timeline from signup to results, based on standard semaglutide titration:

  1. Day 1 — Questionnaire. Sign up, complete the 10-minute health intake, upload any requested info (photo ID, sometimes weight photos or labs).

  2. Same day to 72 hours — Provider review. A licensed provider reviews your case. Oak Loves You offers same-day approval; most platforms respond within 1-3 business days.

  3. Days 3-10 — Medication arrives. Shipped cold with injection supplies and instructions. Pre-mixed and ready to use.

  4. Weeks 1-4 — Starting dose (0.25mg semaglutide weekly). This dose is for tolerance, not weight loss. Mild nausea is the most common side effect — eat smaller meals, avoid greasy food, stay hydrated. It usually fades within a few weeks.

  5. Weeks 5-8 — First dose increase (0.5mg weekly). Appetite suppression becomes noticeable for most people. “Food noise” quiets down. Some patients start seeing the scale move here.

  6. Weeks 9-12 — Continued titration. Your provider adjusts the dose based on your response and side effects. Average results: 5-8% body weight loss by month 3 on semaglutide, with the steeper losses coming in months 4-12 as you reach therapeutic doses.

Manage expectations: The first month is about tolerance, not transformation. If you quit at week 3 because "nothing is happening," you quit before the medication reached a working dose. Give it the full 12 weeks before judging.

Frequently Asked Questions #

Is compounded semaglutide legal in 2026?

It depends on how it’s made. The FDA declared the semaglutide shortage over in February 2025 (tirzepatide in December 2024), and the grace period for mass compounding ended in mid-2025. Large-batch compounded GLP-1s from 503B outsourcing facilities are no longer permitted. However, compounding remains legal through state-licensed 503A pharmacies when a prescriber documents an individualized clinical need for a specific patient — such as a dose that isn’t commercially available. In April 2026, the FDA proposed removing semaglutide and tirzepatide from the 503B bulk substances list entirely and issued roughly 30 warning letters to compounders. Legitimate telehealth platforms now work with 503A pharmacies and individualized prescriptions. Verify that your platform uses a state-licensed US pharmacy.

What’s the difference between compounded and brand-name semaglutide?

Brand-name semaglutide (Ozempic, Wegovy) is FDA-approved and manufactured by Novo Nordisk. Compounded semaglutide contains the same active ingredient but is prepared by a licensed compounding pharmacy for an individual patient under a prescription. Compounded versions are not FDA-approved and don’t go through FDA review — which is why choosing a platform that uses a state-licensed US 503A pharmacy matters. The price gap is dramatic: roughly $1,000-1,349 per month list price for brand-name versus $129-199 per month for compounded semaglutide.

Do I need insurance to get GLP-1 medications through telehealth?

No. All telehealth platforms listed are cash-pay. No insurance needed, no prior authorizations, no denials to fight.

Do telehealth GLP-1 platforms take insurance or HSA/FSA?

These platforms are cash-pay and do not bill insurance. Some accept HSA/FSA cards — check with the platform before signing up. If you want brand-name medication without insurance, the manufacturer direct-pay programs (NovoCare Pharmacy for Wegovy, LillyDirect for Zepbound) offer self-pay pricing of roughly $349-499 per month.

What BMI do I need to qualify for a telehealth GLP-1 prescription?

Typically BMI 30 or higher, or BMI 27 or higher with at least one weight-related condition such as sleep apnea, high blood pressure, prediabetes, high cholesterol, PCOS, arthritis, or fatty liver disease. A licensed provider makes the final call based on your full health profile.

Can I switch from Ozempic or Wegovy to compounded semaglutide?

Yes, and it’s common. Tell your telehealth provider your current medication and dose — they’ll typically continue you at the equivalent compounded dose rather than restarting titration at 0.25mg. Have your prescription history or pharmacy records ready to document your current dose.

Are there non-injection GLP-1 options through telehealth?

Yes. ShedRx offers GLP-1 drops and lozenges as needle-free alternatives. YourEra Health also provides compounded semaglutide from $99/month with their own pharmacy. Keep in mind that oral and sublingual absorption differs from injection, and the injectable route remains the best-studied.

What states do telehealth GLP-1 platforms cover?

Most platforms cover most or all US states — Oak Loves You operates in all 50 states. Availability depends on where the platform’s providers and partner pharmacy are licensed. You enter your state during signup and find out immediately whether you’re covered.

How long until I get my medication?

Typically 3-10 business days after approval. Oak Loves You offers same-day approval with free shipping.

Can I use telehealth GLP-1s for health conditions beyond weight loss?

Yes. Telehealth providers prescribe based on your overall health profile. If you qualify for a GLP-1 prescription (typically BMI 27+ with comorbidities or 30+), you’ll receive the same medication regardless of your primary motivation — whether it’s weight management, inflammation, joint pain, or metabolic health.


Key References #

  1. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. DOI
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. DOI

I'm not a doctor — just someone researching GLP-1 medications thoroughly. Always consult your healthcare provider before starting any new medication.

Questions? contact@glp1forwellness.com

Affiliate Disclosure: Some links earn a small commission at no extra cost to you. I only recommend platforms I've researched thoroughly.